Robert Gerberich - Invuity Insider

IVTY -- USA Stock  

USD 3.45  0.025  0.73%

Vice President - Sales and Marketing

Mr. Robert Gerberich is a Vice President Sales and Marketing of the Company. since October 2012. From April 2012 to October 2012 Mr. Gerberich served as Senior Vice President of Global Sales and Field Development at Primcogent Solutions a noninvasive lowlevel laser therapy company. From January 2006 to April 2012 Mr. Gerberich served as President of UltraShape North America. Prior to UltraShape Mr. Gerberich served as the Vice President of Marketing and Sales and Vice President of Sales at Thermage Inc. a medical device company
Age: 47  President Since 2012      
Gerberich received a B.S. in marketing from Illinois State University.

Management Efficiency

The company has return on total asset (ROA) of (33.67) % which means that it has lost $33.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (231.01) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 33.57 M in liabilities with Debt to Equity (D/E) ratio of 317.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity has Current Ratio of 3.31 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets. It employs 161 people.Invuity (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 161 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.

Invuity Leadership Team

Robert Gerberich, President
Douglas Heigel, VP
Daniel Wolterman, Director
Alex Vayser, Founder
William Burke, Director, MBA
Philip Sawyer, CEO, MBA
Eric Roberts, Director
Andrew Sale, President
Scott Flora, Director
Gregory Brown, Executive, MBA
James Mackaness, CFO
Steve Annen, President
Joseph Guido, President, MBA
Randall Lipps, Director
Paul Davison, VP
Reza Zadno, Director, Ph.D
Brett Robertson, Executive
Gregory Lucier, Chairman, MBA
Marcia Fish, Executive, MBA

Stock Performance Indicators

Did you try this?

Run Equity Valuation Now

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Equity Valuation

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.